As of Jul 29
| +0.50 / +0.47%|
The 20 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 125.50, with a high estimate of 150.00 and a low estimate of 114.00. The median estimate represents a +17.29% increase from the last price of 107.00.
The current consensus among 26 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.